13 Dec, 2025
3 mins read

Lexington Officials Emphasize Severe Weather Preparedness During Citywide Emergency Summit

Today, city leaders met at the Lexington Convention Centre in a critical emergency summit where there was a strong emphasis on extreme weather preparedness due to the increasing climate threats. More than 500 residents, first responders and experts attended the event, which was devoted to ways of protecting communities against tornadoes, floods and extreme storms […]

3 mins read

Lexington Entertainment District Proposal Ignites Community Debate Across the City

The suggestion to create a new entertainment district in downtown Lexington has led to heated debates between people, business owners, and city officials. The Lexington Urban Development Council has proposed a plan that will see a 20-acre area surrounding the historic area turned into a vibrant centre that will host theatres, restaurants, live music bars […]

5 mins read

Lexington Community Rallies to Save Endangered Horse Farm Amid Development Threats in 2025

The Bluegrass Horse Farm, a legendary Lexington farm, is at the onset of a serious danger due to urbanisation, which has rocked the animal lovers and preservationists in the state of Kentucky. Local activists have also gone on the offensive as of December 11, 2025, to preserve the 150-year-old property, which has a collection of […]

5 mins read

The Railyard Breaks Ground: $7.5 Million Mixed-Use Development Transforms Lexington’s Delaware Avenue

In a major advancement towards the urban revitalisation process in Lexington, the Railyard project was officially launched on December 3, 2025, with a new dawn in affordable housing and community development in the city. This 7.5 million mixed-use project at 1000 Delaware Avenue will integrate residential housing with shopping areas to not only help meet […]

4 mins read

Voyager Therapeutics Announces Setback In SOD1 ALS Gene Therapy Program

Voyager Therapeutics, a company that specializes in bioinformatics, has announced a significant update to its gene therapy program for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). The company informed on Tuesday, February 11, 2025, that it would be experimenting with other main deliveries for its SOD1 ALS gene therapy program due to the singular […]